Correlation Between Estrella Immunopharma and Aytu BioScience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Estrella Immunopharma and Aytu BioScience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Estrella Immunopharma and Aytu BioScience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Estrella Immunopharma and Aytu BioScience, you can compare the effects of market volatilities on Estrella Immunopharma and Aytu BioScience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Estrella Immunopharma with a short position of Aytu BioScience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Estrella Immunopharma and Aytu BioScience.

Diversification Opportunities for Estrella Immunopharma and Aytu BioScience

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Estrella and Aytu is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Estrella Immunopharma and Aytu BioScience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aytu BioScience and Estrella Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Estrella Immunopharma are associated (or correlated) with Aytu BioScience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aytu BioScience has no effect on the direction of Estrella Immunopharma i.e., Estrella Immunopharma and Aytu BioScience go up and down completely randomly.

Pair Corralation between Estrella Immunopharma and Aytu BioScience

Assuming the 90 days horizon Estrella Immunopharma is expected to generate 0.13 times more return on investment than Aytu BioScience. However, Estrella Immunopharma is 7.47 times less risky than Aytu BioScience. It trades about -0.58 of its potential returns per unit of risk. Aytu BioScience is currently generating about -0.16 per unit of risk. If you would invest  9.20  in Estrella Immunopharma on September 1, 2024 and sell it today you would lose (0.10) from holding Estrella Immunopharma or give up 1.09% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy14.29%
ValuesDaily Returns

Estrella Immunopharma  vs.  Aytu BioScience

 Performance 
       Timeline  
Estrella Immunopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days Estrella Immunopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly weak basic indicators, Estrella Immunopharma showed solid returns over the last few months and may actually be approaching a breakup point.
Aytu BioScience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aytu BioScience has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Estrella Immunopharma and Aytu BioScience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Estrella Immunopharma and Aytu BioScience

The main advantage of trading using opposite Estrella Immunopharma and Aytu BioScience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Estrella Immunopharma position performs unexpectedly, Aytu BioScience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aytu BioScience will offset losses from the drop in Aytu BioScience's long position.
The idea behind Estrella Immunopharma and Aytu BioScience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stocks Directory
Find actively traded stocks across global markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities